These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 12187801)

  • 1. [Insulin dependency of diabetes mellitus in the elderly].
    Kotani R; Nagata M; Yokono K
    Nihon Ronen Igakkai Zasshi; 2002 Jul; 39(4):393-5. PubMed ID: 12187801
    [No Abstract]   [Full Text] [Related]  

  • 2. [Autoantibodies in type 1 diabetes mellitus].
    Ziegler M; Ziegler B
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):561-5. PubMed ID: 7856261
    [No Abstract]   [Full Text] [Related]  

  • 3. The pathogenesis of insulin-dependent diabetes mellitus.
    Atkinson MA; Maclaren NK
    N Engl J Med; 1994 Nov; 331(21):1428-36. PubMed ID: 7969282
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoreactivity to a 64,000 Mr human islet cell antigen in sera from insulin-dependent diabetes mellitus patients and individuals with abnormal glucose tolerance.
    Baekkeskov S
    Mol Biol Med; 1986 Apr; 3(2):137-42. PubMed ID: 3526081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Islet cell antibodies].
    Hanafusa T
    Rinsho Byori; 1995 May; 43(5):460-2. PubMed ID: 7783363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantigens in insulin-dependent diabetes mellitus: molecular cloning and characterization of human IA-2 beta.
    Li Q; Borovitskaya AE; DeSilva MG; Wasserfall C; Maclaren NK; Notkins AL; Lan MS
    Proc Assoc Am Physicians; 1997 Jul; 109(4):429-39. PubMed ID: 9220540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to multiple islet autoantigens in patients with abrupt onset type 1 diabetes and diabetes diagnosed with urinary glucose screening.
    Sera Y; Kawasaki E; Abiru N; Ozaki M; Abe T; Takino H; Kondo H; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S; Uchigata Y; Matsuura N; Eguchi K
    J Autoimmun; 1999 Sep; 13(2):257-65. PubMed ID: 10479394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of ICA512 antibodies for prediction and diagnosis of type 1 diabetes.
    Mayrhofer M; Rabin DU; Messenger L; Standl E; Ziegler AG
    Exp Clin Endocrinol Diabetes; 1996; 104(3):228-34. PubMed ID: 8817240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of NOD mice in the study of type 1 diabetes.
    Karounos DG; Goes SE
    Methods Mol Med; 2003; 83():81-90. PubMed ID: 12619718
    [No Abstract]   [Full Text] [Related]  

  • 10. Autoantibodies to ICA12 (SOX-13) are not specific for Type I diabetes.
    Steinbrenner H; Lohmann T; Ostendorf B; Scherbaum WA; Seissler J
    Diabetologia; 2000 Nov; 43(11):1381-4. PubMed ID: 11126406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of the pathogenesis of beta-cell destruction in insulin-dependent diabetes mellitus.
    Lernmark A; Bärmeier H; Dube S; Hagopian W; Karlsen AE; Markholst H; Wilson C; Wassmuth R
    West J Med; 1990 Nov; 153(5):499-502. PubMed ID: 1979704
    [No Abstract]   [Full Text] [Related]  

  • 12. beta-Cell death during progression to diabetes.
    Mathis D; Vence L; Benoist C
    Nature; 2001 Dec; 414(6865):792-8. PubMed ID: 11742411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies on humoral immune markers of insulin-dependent diabetes mellitus.
    Falorni A; Kassi G; Murdolo G; Calcinaro F
    J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():307-17. PubMed ID: 9642661
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mechanism and genetic control of the autoimmune response directed against beta-pancreatic cells in insulin-dependent diabetes].
    Michelsen B; Baekkeskov S; Deufel T; Kastern W; Kofod H; Lernmark A; Vissing H
    Journ Annu Diabetol Hotel Dieu; 1985; ():171-82. PubMed ID: 2577960
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
    Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A better crystal ball.
    Rusting R
    Sci Am; 1988 Aug; 259(2):24, 26. PubMed ID: 3064292
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular targeting of islet autoantigens.
    Stadinski B; Kappler J; Eisenbarth GS
    Immunity; 2010 Apr; 32(4):446-56. PubMed ID: 20412755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunoenzyme determination of antibodies to the surface of islands of Langerhans in autoimmune destruction of the insular apparatus].
    Kondrat'ev IaIu; Sadovnikova NV; Fedotov VP; Liozner AL
    Biull Eksp Biol Med; 1986 Jan; 101(1):63-5. PubMed ID: 3510673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Type 1 or Type 2 diabetes: diagnostic aids in clinically uncertain cases].
    Spinas GA
    Schweiz Rundsch Med Prax; 1991 Dec; 80(49):1367-8. PubMed ID: 1745887
    [No Abstract]   [Full Text] [Related]  

  • 20. Does GAD have a unique role in triggering IDDM?
    Baekkeskov S; Kanaani J; Jaume JC; Kash S
    J Autoimmun; 2000 Nov; 15(3):279-86. PubMed ID: 11040068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.